BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16537031)

  • 21. Protective and therapeutic efficacy study of divalent fusion protein rL7/L12-Omp25 against B. abortus 544 in presence of IFNγ.
    Paul S; Peddayelachagiri BV; Nagaraj S; Konduru B; Batra HV
    Appl Microbiol Biotechnol; 2018 Oct; 102(20):8895-8907. PubMed ID: 30136204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity of adenovirus and DNA vaccines co-expressing P39 and lumazine synthase proteins of Brucella abortus in BALB/c mice.
    Lin GZ; Yang JT; Wei SC; Chen SE; Huo SD; Ma ZR
    Trop Anim Health Prod; 2018 Jun; 50(5):957-963. PubMed ID: 29492808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.
    Singh D; Somani VK; Aggarwal S; Bhatnagar R
    Mol Immunol; 2015 Dec; 68(2 Pt A):272-9. PubMed ID: 26442664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of partial protection in mice after oral administration of Lactococcus lactis producing Brucella abortus L7/L12 antigen.
    Pontes DS; Dorella FA; Ribeiro LA; Miyoshi A; Le Loir Y; Gruss A; Oliveira SC; Langella P; Azevedo V
    J Drug Target; 2003; 11(8-10):489-93. PubMed ID: 15203917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substantial Protective Immunity Conferred by a Combination of
    Arayan LT; Huy TXN; Reyes AWB; Hop HT; Son VH; Min W; Lee HJ; Kim S
    J Microbiol Biotechnol; 2019 Feb; 29(2):330-338. PubMed ID: 30609879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune responses of mice to vaccinia virus recombinants expressing either Listeria monocytogenes partial listeriolysin or Brucella abortus ribosomal L7/L12 protein.
    Baloglu S; Boyle SM; Vemulapalli R; Sriranganathan N; Schurig GG; Toth TE
    Vet Microbiol; 2005 Aug; 109(1-2):11-7. PubMed ID: 15941627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a protective protein from stationary-phase exoproteome of Brucella abortus.
    Jain S; Kumar S; Dohre S; Afley P; Sengupta N; Alam SI
    Pathog Dis; 2014 Feb; 70(1):75-83. PubMed ID: 23913725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of immunogenicity and protective efficacy of a plasmid DNA vaccine encoding ribosomal protein L9 of Brucella abortus in BALB/c mice.
    Jain S; Afley P; Dohre SK; Saxena N; Kumar S
    Vaccine; 2014 Jul; 32(35):4537-4542. PubMed ID: 24950353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Escheriosomes entrapped DNA vaccine co-expressing Cu-Zn superoxide dismutase and IL-18 confers protection against Brucella abortus.
    Singha H; Mallick AI; Jana C; Isore DP; Goswami TK; Srivastava SK; Azevedo VA; Chaudhuri P; Owais M
    Microbes Infect; 2008; 10(10-11):1089-96. PubMed ID: 18602490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A combined DNA vaccine encoding BCSP31, SOD, and L7/L12 confers high protection against Brucella abortus 2308 by inducing specific CTL responses.
    Yu DH; Hu XD; Cai H
    DNA Cell Biol; 2007 Jun; 26(6):435-43. PubMed ID: 17570767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraperitoneal administration of a novel chimeric immunogen (rOP) elicits IFN-γ and IL-12p70 protective immune response in BALB/c mice against virulent Brucella.
    Tadepalli G; Konduru B; Murali HS; Batra HV
    Immunol Lett; 2017 Dec; 192():79-87. PubMed ID: 29106986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
    Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.
    Delpino MV; Estein SM; Fossati CA; Baldi PC; Cassataro J
    Vaccine; 2007 Sep; 25(37-38):6721-9. PubMed ID: 17686554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy evaluation of live Escherichia coli expression Brucella P39 protein combined with CpG oligodeoxynucleotides vaccine against Brucella melitensis 16M, in BALB/c mice.
    Al-Mariri A; Mahmoud NH; Hammoud R
    Biologicals; 2012 Mar; 40(2):140-5. PubMed ID: 22296786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization with recombinant GntR plasmid confers protection against Brucella challenge in BALB/c mice.
    Li Z; Wang S; Zhang H; Xi L; Zhang J; Zhang X; Han J; Zhang J
    Microb Pathog; 2017 Oct; 111():357-361. PubMed ID: 28916314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced cerebral infection of Neospora caninum in BALB/c mice vaccinated with recombinant Brucella abortus RB51 strains expressing N. caninum SRS2 and GRA7 proteins.
    Vemulapalli R; Sanakkayala N; Gulani J; Schurig GG; Boyle SM; Lindsay DS; Sriranganathan N
    Vet Parasitol; 2007 Sep; 148(3-4):219-30. PubMed ID: 17651896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel influenza virus vectors expressing Brucella L7/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection.
    Tabynov K; Kydyrbayev Z; Ryskeldinova S; Yespembetov B; Zinina N; Assanzhanova N; Kozhamkulov Y; Inkarbekov D; Gotskina T; Sansyzbay A
    Vaccine; 2014 Apr; 32(18):2034-41. PubMed ID: 24598723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Brucella abortus DNA and RNA vaccines expressing Cu-Zn superoxide dismutase (SOD) gene in cattle.
    Sáez D; Guzmán I; Andrews E; Cabrera A; Oñate A
    Vet Microbiol; 2008 Jun; 129(3-4):396-403. PubMed ID: 18164561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice.
    Velikovsky CA; Cassataro J; Giambartolomei GH; Goldbaum FA; Estein S; Bowden RA; Bruno L; Fossati CA; Spitz M
    Infect Immun; 2002 May; 70(5):2507-11. PubMed ID: 11953389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A combined DNA vaccine enhances protective immunity against Mycobacterium tuberculosis and Brucella abortus in the presence of an IL-12 expression vector.
    Yu DH; Li M; Hu XD; Cai H
    Vaccine; 2007 Sep; 25(37-38):6744-54. PubMed ID: 17681650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.